These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7535554)

  • 1. In vivo models for testing of cytostatic agents in non-small cell lung cancer.
    Kal HB
    Cancer Treat Res; 1995; 72():155-69. PubMed ID: 7535554
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.
    Mattern J; Wayss K; Volm M
    In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative chemotherapy. Xenografts and in vitro drug sensitivity testing.
    Gazdar AF
    Chest; 1989 Jul; 96(1 Suppl):56S-59S. PubMed ID: 2544362
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated irradiation under ambient conditions of human NSCLC transplanted into nude mice: effect of different fractionation schedules and of radiotherapy and vindesine.
    Hinkelbein W; Wallbrecher E; Fiebig HH; Wannenmacher M
    Strahlenther Onkol; 1989 Jul; 165(7):519-20. PubMed ID: 2546268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
    Bergman B
    Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor and antiproliferative effects of an aqueous extract from the marine diatom Haslea ostrearia (Simonsen) against solid tumors: lung carcinoma (NSCLC-N6), kidney carcinoma (E39) and melanoma (M96) cell lines.
    Carbonnelle D; Pondaven P; Morancais M; Masse G; Bosch S; Jacquot C; Briand G; Robert J; Roussakis C
    Anticancer Res; 1999; 19(1A):621-4. PubMed ID: 10226609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
    Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.
    Kruczynski A; Kiss R
    Anticancer Res; 1993; 13(2):507-13. PubMed ID: 7685990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which non-small-cell lung cancer patients achieve long-term survival?
    Ahbeddou N; Fetohi M; Boutayeb S; Errihani H
    Indian J Cancer; 2011; 48(4):514-5. PubMed ID: 22293271
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft.
    Kelner MJ; McMorris TC; Estes L; Samson KM; Bagnell RD; Taetle R
    Eur J Cancer; 1998 May; 34(6):908-13. PubMed ID: 9797706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
    Bogden AE; Carde P; de Paillette ED; Moreau JP; Tubiana M; Frindel E
    Ann N Y Acad Sci; 1991; 628():126-39. PubMed ID: 1648882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of tumor markers in monitoring of cytotoxic treatment of non-small cell lung cancer].
    Załeska M
    Pneumonol Alergol Pol; 2003; 71(7-8):359-64. PubMed ID: 15052970
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
    Harper E; Dang W; Lapidus RG; Garver RI
    Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice.
    Honma Y; Yamamoto-Yamaguchi Y; Kanatani Y
    Br J Cancer; 1999 Apr; 80(1-2):96-103. PubMed ID: 10389984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
    Heike Y; Takahashi M; Ohira T; Arioka H; Funayama Y; Nishio K; Ogasawara H; Saijo N
    Cancer Chemother Pharmacol; 1995; 35(3):200-4. PubMed ID: 7805177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of pachymatismin, a new marine glycoprotein, on a human non-small-cell lung carcinoma.
    Zidane M; Moré MT; Pondaven P; Jaquot C; Riou D; Roussakis C
    In Vivo; 1997; 11(2):185-8. PubMed ID: 9179614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel Her-1/Her-2 dual tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-resistant non-small cell lung cancer.
    Cha MY; Lee KO; Kim JW; Lee CG; Song JY; Kim YH; Lee GS; Park SB; Kim MS
    J Med Chem; 2009 Nov; 52(21):6880-8. PubMed ID: 19888761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.